(Q48412710)

11 February 2018

title

Assessing HRQOL: a neglected issue for high-grade glioma. (English)

1 reference

11 February 2018

2

Andrew Bottomley

1 reference

11 February 2018

1

Fabio Efficace

1 reference

11 February 2018

publication date

1 January 2003

1 reference

11 February 2018

Lancet Oncology Commission

published in

1 reference

11 February 2018

volume

4

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

11-12

1 reference

11 February 2018

Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

Reporting on quality of life in randomised controlled trials: bibliographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

Who should measure quality of life, the doctor or the patient?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

Pion radiation for high grade astrocytoma: results of a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

Quality of life in patients with glioblastoma multiforme participating in a randomized study of brachytherapy as a boost treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2900955-0

7 January 2021

10.1016/S1470-2045(03)00955-0

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018